Taizo Matsuki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model.

Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model.

Journal: Expert review of vaccines

Published: May 22, 2026

Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study.

Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: May 13, 2026

Public health impact and cost-effectiveness of implementing gender-neutral vaccination with a 9-valent HPV vaccine in Japan: a modeling study.

Public health impact and cost-effectiveness of implementing gender-neutral vaccination with a 9-valent HPV vaccine in Japan: a modeling study.

Journal: Journal of medical economics

Published: June 18, 2025

The public health impact of extending the catch-up nonavalent human papillomavirus vaccination program to 2028 in Japan: a model-based study.

The public health impact of extending the catch-up nonavalent human papillomavirus vaccination program to 2028 in Japan: a model-based study.

Journal: BMC public health

Published: May 28, 2025

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan.

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan.

Journal: PharmacoEconomics - open

Published: April 08, 2025

Health and economic impact of the 21-valent pneumococcal conjugate vaccine (V116) for adults in Japan: a delta price approach.

Health and economic impact of the 21-valent pneumococcal conjugate vaccine (V116) for adults in Japan: a delta price approach.

Journal: Journal of medical economics

Published: December 20, 2024

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan.

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan.

Journal: Expert review of vaccines

Published: October 22, 2024

Holistic Evaluation of the Gut Microbiota through Data Envelopment Analysis: A Cross-Sectional Study.

Holistic Evaluation of the Gut Microbiota through Data Envelopment Analysis: A Cross-Sectional Study.

Journal: Current developments in nutrition

Published: September 19, 2024

Association between gut microbiota and locomotive syndrome risk in healthy Japanese adults: a cross-sectional study.

Association between gut microbiota and locomotive syndrome risk in healthy Japanese adults: a cross-sectional study.

Journal: npj aging

Published: August 06, 2024

Rationale and protocol for a prospective cohort study of respiratory viral infections in patients admitted from emergency departments of community hospitals: Effect of respiratory Virus infection on EmeRgencY admission (EVERY) study.

Rationale and protocol for a prospective cohort study of respiratory viral infections in patients admitted from emergency departments of community hospitals: Effect of respiratory Virus infection on EmeRgencY admission (EVERY) study.

Journal: BMJ open

Published: April 16, 2024

Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatients.

Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatients.

Journal: Respiratory investigation

Published: April 12, 2024

Health Status Progression Measured Using Weekly Telemonitoring of COPD Assessment Test Scores Over 1 Year and Its Association With COPD Exacerbations.

Health Status Progression Measured Using Weekly Telemonitoring of COPD Assessment Test Scores Over 1 Year and Its Association With COPD Exacerbations.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: March 05, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026